Athira Pharma, Inc. closed fiscal year 2025 with $92.2M in total assets, $64.4M in total liabilities and $27.8M in shareholder equity. Total assets rose 56.8% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Athira Pharma, Inc. has filed alongside them.
Ticker history: ATHA became LONA (LeonaBio, Inc.) on .
Annual figures, oldest first. Point at a bar to read its period.
ATHA Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $92.2M+56.8% | $58.8M-63.3% | $160.2M-37.9% | $258.2M-22.2% | $332.0M+18.8% | $279.6M+12671.3% | $2.2M |
| Total Liabilities | $64.4M+361.8% | $13.9M-53.6% | $30.1M+30.6% | $23.0M+110.7% | $10.9M+106.9% | $5.3M-75.9% | $21.9M |
| Total Equity | $27.8M-38.0% | $44.8M-65.6% | $130.2M-44.6% | $235.1M-26.8% | $321.1M+17.1% | $274.3Mn/m | -$19.7M |
ATHA Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $71.6M+64.5% | $92.2M+56.8% | $30.0M-65.2% | $35.5M-68.1% | $43.5M-67.4% | $58.8M-63.3% | $86.2M-53.3% | $111.3M-46.5% | $133.5M-42.7% | $160.2M-37.9% | $184.7M-32.6% | $208.0M-28.8% |
| Total Liabilities | $22.3M+260.5% | $64.4M+361.8% | $3.2M-88.7% | $3.6M-87.3% | $6.2M-76.9% | $13.9M-53.6% | $28.7M-4.3% | $27.9M+21.0% | $26.7M+23.4% | $30.1M+30.6% | $29.9M+150.8% | $23.1M+101.5% |
| Total Equity | $49.3M+32.1% | $27.8M-38.0% | $26.8M-53.5% | $32.0M-61.6% | $37.3M-65.0% | $44.8M-65.6% | $57.6M-62.8% | $83.3M-54.9% | $106.7M-49.4% | $130.2M-44.6% | $154.8M-41.0% | $185.0M-34.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Athira Pharma, Inc. financials
Frequently Asked Questions
Athira Pharma, Inc. closed fiscal year 2025 with $92.2M in total assets, $64.4M in total liabilities and $27.8M in shareholder equity.
Athira Pharma, Inc. (ATHA) total assets rose by 56.8% year over year, from $58.8M to $92.2M in fiscal year 2025.
Across the 7 fiscal years this page covers, Athira Pharma, Inc. (ATHA) total assets went from $2.2M in fiscal year 2019 to $92.2M in fiscal year 2025.
Athira Pharma, Inc. (ATHA) reported $71.6M in total assets in Q1 2026. This represents an increase of 64.5% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Athira Pharma, Inc. (ATHA) reported on that line in every period on record.